Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients?

Area of Science:

• Cardiology
• Vascular Surgery
• Anesthesiology

Background:

• Cardiac complications are a major cause of death and disability in patients undergoing vascular surgery.
• Underlying coronary artery disease contributes significantly to these cardiac risks.
• The benefit of pre-operative coronary revascularization in this patient group remains a long-standing debate.

Purpose of the Study:

• To review the current evidence regarding pre-operative coronary revascularization before elective vascular surgery.
• To evaluate the impact of pre-operative revascularization on peri-operative and long-term cardiac outcomes.

Main Methods:

• Review of published studies, including the Coronary Artery Revascularization Prophylaxis (CARP) trial.
• Analysis of outcomes in patients undergoing pre-operative coronary revascularization versus optimized medical therapy.

Main Results:

• The CARP trial found no reduction in post-operative myocardial infarctions, deaths, or hospital stay with pre-operative revascularization.
• Long-term outcomes were also not improved by pre-operative coronary revascularization compared to medical therapy.

Conclusions:

• Current evidence, including the CARP trial, suggests that pre-operative coronary revascularization does not offer significant benefits for cardiac outcomes in patients undergoing elective vascular surgery.
• Optimized medical therapy appears to be a comparable strategy for managing cardiac risk in these patients.